Appropriate selection for omalizumab treatment in patients with severe asthma?
Background: Omalizumab improves asthma control in patients with uncontrolled severe allergic asthma; however, appropriate patient selection is crucial. Information in this field is sparse. Objective: We aimed to estimate whether potential omalizumab candidates were appropriately selected according t...
Main Authors: | Leo Nygaard, Daniel Pilsgaard Henriksen, Hanne Madsen, Jesper Rømhild Davidsen |
---|---|
Format: | Article |
Language: | English |
Published: |
Taylor & Francis Group
2017-01-01
|
Series: | European Clinical Respiratory Journal |
Subjects: | |
Online Access: | http://dx.doi.org/10.1080/20018525.2017.1359477 |
Similar Items
-
A review of omalizumab for the management of severe asthma
by: Lin CH, et al.
Published: (2016-07-01) -
Sex, Allergic Diseases and Omalizumab
by: Maria Maddalena Sirufo, et al.
Published: (2022-01-01) -
FENOMA Study: Achieving Full Control in Patients with Severe Allergic Asthma
by: Cabrejos S, et al.
Published: (2020-05-01) -
Omalizumab: An Optimal Choice for Patients with Severe Allergic Asthma
by: Serafeim Chrysovalantis Kotoulas, et al.
Published: (2022-01-01) -
Efficacy of omalizumab in children, adolescents, and adults with severe allergic asthma: a systematic review, meta-analysis, and call for new trials using current guidelines for assessment of severe asthma
by: Daniel P. Henriksen, et al.
Published: (2020-06-01)